The advanced science behind the technology – milMED Delivery System
Our story begins with over a decade of research and patents in the U.S. and through the World Intellectual Property Organization (WIPO). By using novel bioactive molecules, this technology has paved the way for the first biocompatible approach to active ingredient delivery and enhanced absorption. It offers high performance at a lower cost by creating small molecular structures that increase absorption and support long-term health.
Biomimetics
The milMED Delivery System, a scientific platform, is designed to create small molecular structures that are biocompatible, more easily functionalized, and customized in a variety of sizes to enable targeted penetration into each target cell or tissue site.
Small molecular structures enhance absorption
The milMED Delivery System is a US patent of Moonshot Biotech PTE. LTD. (Singapore) that creates high-performance small molecule structures that enhance absorption efficiency. The addition of exclusive biotechnological ingredients to the product significantly increases the effectiveness of the impact, maintaining the stability of the active ingredient in the body. Enhanced absorption efficiency is a pioneering factor in solving the problem of poor absorption and weakness.
Strengthening immunity is the solution to protect sustainable health
milMED has over 15 years of experience in improving the quality of care for primary immune deficiency disorders. A healthy immune system protects us from the risk of disease or antigens entering the body. Technology helps us activate the natural immune system to function, strengthening the immune system.
Technology that supports immunity
Scientific and technological nutrition products
Optren is a line of scientific nutritional products containing active ingredients that are brought into a small molecular transport structure based on exclusive technology patented in the US (US patent) with a balanced nutritional system that supports the improvement of specific health problems such as cardiovascular disease, diabetes, cancer, physical weakness, and immune deficiency.
A sustainable future begins with technology
We develop technologies based on natural biology, preserving the structure of active ingredients for a sustainable future. We keep our operations lean and are not afraid to eliminate what doesn’t work. Our unique technology allows us to build platforms from lab to industrial scale, pushing the boundaries of science.
